TECVAYLI

Indicated For

multiple myeloma

About This Medication

# Johnson & Johnson Patient Assistance Program Patient Guide: How to Get TECVAYLI (teclistamab-cqyv) at Low or No Cost TECVAYLI (teclistamab-cqyv) is a prescription medication used to treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This guide explains how the **Johnson & Johnson Patient Assistance Program** can help eligible patients get TECVAYLI at no cost for up to one year if financial or insurance barriers make it hard to afford.[1][5] ## About TECVAYLI and Why Assistance Matters **TECVAYLI** is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager administered via subcutaneous injection. It works by helping the immune system target and kill multiple myeloma cells. Multiple myeloma is a type of blood cancer that affects plasma cells in the bone marrow, often requiring multiple treatments over time. Treatment costs can exceed $100,000 per year, making patient assistance programs essential for many.[1][5] The **Johnson & Johnson Patient Assistance Program**, run by Janssen (a Johnson & Johnson company), provides free medication to uninsured, underinsured, or insured patients whose coverage doesn't fully meet their needs. If approved, you receive up to a **one-year supply** shipped directly to your home, doctor's office, or treatment center—no copays or deductibles required through the program.[1][2][5] ## Who Qualifies? To qualify, you must: - Live in the United States or a U.S. territory.[1] - Have a valid prescription for TECVAYLI from a U.S.-licensed physician for outpatient use.[1][2] - Meet **income eligibility** at or below **400% of the Federal Poverty Level (FPL)** based on household size and income.[1][2] - Fit insurance criteria: uninsured, underinsured, commercially insured with inadequate coverage, Medicare, or Medicaid.[1][2][4] **Special notes for Medicare Part D patients**: You may qualify if you spend more than **4% of your gross annual household income** on prescription drugs and are not eligible for Low-Income Subsidy (LIS) if your income is ≤150% FPL.[1][2][4] ## Income Eligibility Breakdown Eligibility is based on household income at or below **400% of the FPL**. Use the table below for 2026 guidelines (FPL updates annually; confirm current levels at enrollment).[1][2] | Household Size | Annual Income Limit (400% FPL) | |----------------|-------------------------------| | 1 (Individual) | $60,320 | | 2 (Couple) | $81,760 | | 3 | $103,200 | | 4 | $124,640 | | +1 per member | +$21,440 | *Notes*: Income includes all household earnings. Provide proof like your most recent 1040 tax return. Puerto Rico residents need additional financial docs like Form 482 or AS 6088.1.[2][3] ## Insurance Requirements The program accepts: - **Uninsured** patients. - **Underinsured** or **commercially insured** with coverage that doesn't cover full costs. - **Medicare/Medicaid** patients meeting spend thresholds (e.g., >4% income on drugs for Part D).[1][2][4] If insured, submit front/back copies of insurance cards. Medicare Part D patients may need pharmacy reports or EOBs showing out-of-pocket costs. The program doesn't cover treatment administration costs—only the medication.[2][3][4] ## Step-by-Step Application Process 1. **Gather Documents**: Proof of residency (e.g., utility bill), proof of income (1040 tax return), prescription, insurance info (cards or denial letter).[1][2][3] 2. **Download Form**: Get the Patient Assistance Enrollment Form from JJPatientAssistance.com. Complete patient sections (personal info, finances, consent on pages 4-7). Have your doctor fill/sign page 3 for TECVAYLI.[2][3] 3. **Submit**: Options include online upload at JJPatientAssistance.com, fax to 833-512-0497, or call (833) 565-9631 / (833) 742-0791 (Mon-Fri, 8 AM-8 PM ET).[1][2][3] 4. **Consent & Authorization**: Sign Patient Consent and Authorization forms online or on the enrollment form. This allows credit/income verification (no credit score impact).[3] 5. **Wait for Review**: Program checks insurance/eligibility and contacts you/doctor with status.[2] **Tip**: Complete all fields accurately—missing info delays processing.[3] ## Timeline and Delivery Processing time varies (typically 2-4 weeks based on completeness), with updates sent to you and your provider. Once approved, medication ships free to your **home**, **physician's office**, or **treatment center**. Coverage lasts up to **one year**; **reauthorization** is required annually.[1][2][5] ## Alternatives if Denied or Ineligible - **Appeal**: Contact the program for reasons and resubmit missing docs.[2] - **Other Janssen Programs**: Explore J&J withMe (JNJwithMe.com) for copay cards, free trial offers, or reimbursement support.[7][8] - **Third-Party Help**: Simplefill ((877) 386-0206) assists with applications/renewals.[1] - **General Resources**: NeedyMeds, RxAssist, or PAN Foundation for multiple myeloma funds. - **No biosimilars** available for TECVAYLI currently.[1] ## Reauthorization and Refills Reapply yearly before supply ends. Update profile for income/insurance changes. Program may request reverification.[1][2][3] ## Important Disclaimer This guide is for informational purposes only and based on publicly available program details as of 2026. Eligibility, terms, and FPL levels can change—always verify at JJPatientAssistance.com or by calling (833) 565-9631. Not medical/financial advice; consult your doctor or advisor. Johnson & Johnson/Janssen reserves rights to modify/terminate the program. By applying, you agree to terms including data use for eligibility.[2][3][5] *Word count: 952*

Program information last verified: March 25, 2026